[Treatment of XXXX by diode semiconductor laser cyclophotocoagulation].

@entity1 @entity1596 @entity726 @entity8814 @entity158 @entity10064
PURPOSE: Ciliary photocoagulation was used to reduce pressure in eyes with @entity726 or to suppress @entity158 . The efficiency of transscleral cyclophotocoagulation (TSCPC) with a clinical diode laser system (Iris Medical Instrument, Oculight SLX) was evaluated. METHODS: This diode laser system (wavelengh: 810 nm) provides light energy to the eye through a specially designed quartz glass fiberoptic probe allowing precise location centered 1.2 mm behind the limbus, i.e. in front of the ciliary body. Thirty eight eyes in 38 @entity1 with @entity726 underwent TSCPC with the diode laser. RESULTS: Three months after surgery, intra-ocular pressure was controlled at 20 mmHg or below in 70% of the @entity1 . @entity1 who most failed with the TSCPC had higher initial IOP (neovascular and @entity10064 ). Seventy five percent of the @entity158 were painless after the laser treatment. Only a few cases (10%) of transient secondary hypertony were observed. The inflammatory response (21%) was mild and transient. No case of scleral perforation, no case of posterior @entity1596 , @entity8814 were observed. CONCLUSION: The transscleral ciliary photocoagulation laser diode system is efficient to reduce intraocular pressure in @entity726 . Complications are mild compared with other methods of cyclophotocoagulation. A long-term study is necessary to evaluate the results on IOP and the incidence of @entity8814 .
